Astrazeneca PLC Sponsored ADR (AZN)

54.76
0.65 1.17
NASDAQ
Prev Close 55.41
Open 54.15
Day Low/High 53.63 / 54.79
52 Wk Low/High 46.48 / 64.21
Volume 6.69M
Exchange NASDAQ
P/E Ratio 51.70
Div & Yield N.A. (N.A)

Latest News

Is Something Up at FibroGen?

* Where is the $100 million of extra cash coming into the company's coffers from between now and year-end?   As I discussed in my thesis, FibroGen has done a great job of right sizing the company and preserving cash as it finances its drug research ...

Moderna's Patent Credit, Palantir and ARK, Musk Sells Tesla as EV Stocks Climb

Moderna's Patent Credit, Palantir and ARK, Musk Sells Tesla as EV Stocks Climb

Plus, the intersection of rising inflation and a slowing velocity of money give us reason for pause.

FibroGen Update

* I have begun to add to my holdings based on the company "right sizing" its operations  FibroGen is a very speculative and development stage biotech company.  Its main product is Roxadustat which treats anemia associated with chronic kidney disease...

How to Play AstraZeneca as Earnings Approach

How to Play AstraZeneca as Earnings Approach

Let's see how the charts are shaping up ahead of the numbers Friday.

Where the S&P and Nasdaq Stand, The New Green Team, Trading Southwest and Pfizer

Where the S&P and Nasdaq Stand, The New Green Team, Trading Southwest and Pfizer

With earnings season starting in earnest Wednesday, both indexes have offered investors nothing but lower highs coupled with lower lows since the start of September.

Taiwan Administers First Home-Made Vaccine

Taiwan Administers First Home-Made Vaccine

Watch Medigen stock, as the Taiwanese president becomes one of the first citizens of the island nation to roll up her sleeve.

What the Fed Said and Did, Robinhood IPO, Trading Ford, Facebook and ServiceNow

What the Fed Said and Did, Robinhood IPO, Trading Ford, Facebook and ServiceNow

Are traders and investors confused? Possibly. Was that the intent? No, but I think Jerome Powell is fine with that.

The Market's Current Mood Brings Back Memories of Late 2018

The Market's Current Mood Brings Back Memories of Late 2018

Just as fears of Fed tightening and a trade war created buying opportunities in tech and elsewhere in late 2018, arguably overblown fears about the Delta variant's economic impact are creating opportunities now.

Dodging the Snakes, Dissonant Dance With China, Dipping Into the Chip Bowl

Dodging the Snakes, Dissonant Dance With China, Dipping Into the Chip Bowl

Those rattles you hear on the COVID, Fed and political fronts are reasons to tread carefully in the markets.

Tech Rally, Acronym Animal Crackers, Fed, Dimon Hands, Trading Banks and SoFi

Tech Rally, Acronym Animal Crackers, Fed, Dimon Hands, Trading Banks and SoFi

The public seems to have resigned itself to dealing with a greater degree of inflation for longer than anything I would have considered to be 'transitory.' The again, the public is often as wrong as the Fed.

If a COVID Vaccine Becomes Seasonal, Watch Novavax: Here's 2 Ways to Trade It

If a COVID Vaccine Becomes Seasonal, Watch Novavax: Here's 2 Ways to Trade It

I prefer the bear put spread over the covered equity play due to the decreased risk to principal, despite the capped potential for profit.

AstraZeneca Is Moving the Needle

AstraZeneca Is Moving the Needle

This drugmaker is making a historic upside breakout. Let's check the charts.

Moderna Could Provide a 'Shot in the Arm' for Your Portfolio

Moderna Could Provide a 'Shot in the Arm' for Your Portfolio

Debt-free and poised to gain from its COVID-19 vaccine demand, MRNA could inject some life into your investment plan.

Welcome to the Show, Trading FedEx and UPS, Vaccine Cavalry, Pfizer's Moment?

Welcome to the Show, Trading FedEx and UPS, Vaccine Cavalry, Pfizer's Moment?

UPS and FDX are both in serious rally mode, yet in very different places in terms of technical development.

Agility Rules, Spoiled Whiners, Smell the May Flowers, Ford in My Future

Agility Rules, Spoiled Whiners, Smell the May Flowers, Ford in My Future

Plus, ServiceNow is a stock worth stalking and Amazon is a stock worth celebrating.

Market Turbulence, Credible FOMC?, GDP, Heavy Earnings Week, COVID in India

Market Turbulence, Credible FOMC?, GDP, Heavy Earnings Week, COVID in India

So far, for the season, the blended rate of earnings growth for the first quarter now stands at an incredible 33.8%.

I'm Not Bailing on Johnson & Johnson Now

I'm Not Bailing on Johnson & Johnson Now

Don't forget, this is a very large company with a lot more than the vaccine going on.

Here's Why I'm Avoiding AstraZeneca Stock

Here's Why I'm Avoiding AstraZeneca Stock

The AZN affair exposes the seedy underbelly of drug manufacturing, and the COVID-19 vaccine is certainly a drug.

Have I Been Given a Dodgy Pfizer Shot in Hong Kong?

Have I Been Given a Dodgy Pfizer Shot in Hong Kong?

Lies, damn lies, and statistics in the vaccine age, as Hong Kong and Macau stop administering the Pfizer/BioNTech drug.

Market Moves, Nasdaq, Be Amphibious, FedCoin, Powell & Yellen, Trading Best Buy

Market Moves, Nasdaq, Be Amphibious, FedCoin, Powell & Yellen, Trading Best Buy

Ever think you would see the day when all cash was digital so the federal government could place a negative interest rate (tax) on savings? I can see this coming from a mile away.

Should You Buy AstraZeneca After Its Positive Vaccine News?

Should You Buy AstraZeneca After Its Positive Vaccine News?

Here's my view on this space and where the money is to be made.

Spring Ahead or Fall Back? No Fear, Nasdaq Uptrend, Trading AbbVie and AMD

Spring Ahead or Fall Back? No Fear, Nasdaq Uptrend, Trading AbbVie and AMD

COVID numbers stopped improving a while ago, even with ever-improving rates of vaccination. Just what is going on here?

Emergent BioSolutions Turns Bearish, So Beware

Emergent BioSolutions Turns Bearish, So Beware

A break in a key support level could precipitate further declines in the life sciences company's shares.

Hopping on a Couple Compelling Opportunities in a Market That Isn't

Hopping on a Couple Compelling Opportunities in a Market That Isn't

Dips in the shares of Redhill Biopharma and FibroGen Inc. provided the chance for the author to employ his covered call strategy.

Biotech Isn't Seeing Much Merger Activity, but Here's a Stock to Like

Biotech Isn't Seeing Much Merger Activity, but Here's a Stock to Like

Dynavax Technologies has inked a supply deal related to a Covid-19 vaccine that could greatly increase its revenue stream.

SPAC Mania, My Short-Sale Rule, Inflation, Bumble IPO, Rivian, Trading Nvidia

SPAC Mania, My Short-Sale Rule, Inflation, Bumble IPO, Rivian, Trading Nvidia

Who knew high finance was so easy? And why the heck was I working so hard? Fundamental analysis is so 1980s.

Lunchtime Reading

Here are some articles that I'll be perusing while I choke down my lunch today:  American Airlines Uncorks Wine Delivery Program To Clear Shelves, Promote Travel MyFreeCams hack: 2 million user records stolen from top adult streaming site and sold o...

The Correction in AstraZeneca Could Be Nearing an End

The Correction in AstraZeneca Could Be Nearing an End

Aggressive traders might want to look past any near-term price weakness and consider a small long position.